Trimetazidine suppresses oxidative stress, inhibits MMP‐2 and MMP‐9 expression, and prevents cardiac rupture in mice with myocardial infarction
Open Access
- 17 July 2018
- journal article
- research article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 36 (5) , e12460
Abstract
Summary: Background/Aims: Cardiac rupture (CR) is a catastrophic complication of acute myocardial infarction (MI). At present, there are no effective pharmacological strategies for preventing post‐MI rupture. Here we investigated the effect of trimetazidine (TMZ) on post‐MI CR.Methods: MI models were induced by left coronary artery ligation in male C57BL/6 mice. Animals allocated to the rupture incidence were closely monitored for 7 days; autopsy was performed once animals were found dead to determine the reason of death. Heart function was detected by echocardiography. Oxidative stress markers and matrix metalloproteinases (MMPs) were analyzed by Western Blotting.Results: TMZ markedly reduced the post‐MI CR incidence of mice. We found that the expression of metalloproteinase (MMP) ‐2 and MMP‐9 in the TMZ‐treated group was significantly lower than the saline‐treated group. Further, TMZ markedly attenuated MI‐induced oxidative stress. To investigate the mechanism of the effect of TMZ on CR, we pretreated H9c2 cells with H2O2 and found that TMZ treatment markedly decreased H2O2‐induced MMP‐2 and MMP‐9 expression. TMZ prevents CR through inhibition of oxidative stress, which is attributable to the down‐regulation of MMP‐2, MMP‐9 expression.Conclusions: Our findings indicate that TMZ suppresses oxidative stress, inhibits MMP‐2 and MMP‐9 expression, and prevents CR in mice with MI.Keywords
Funding Information
- National Natural Science Foundation of China (81600213, 81670222)
This publication has 29 references indexed in Scilit:
- Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusionBasic Research in Cardiology, 2012
- Oxidation of CaMKII determines the cardiotoxic effects of aldosteroneNature Medicine, 2011
- A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the MouseCirculation Research, 2010
- Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase–ROS–CTGF pathwayCardiovascular Research, 2010
- Trimetazidine, Administered at the Onset of Reperfusion, Ameliorates Myocardial Dysfunction and Injury by Activation of p38 Mitogen-Activated Protein Kinase and Akt SignalingThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary EventsEuropean Heart Journal, 2010
- Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effectEuropean Heart Journal, 2007
- Inflammatory Cytokines and Postmyocardial Infarction RemodelingCirculation Research, 2004
- Limitation of Infarct Size by Trimetazidine in the RabbitThe American Journal of Cardiology, 1995